SCHEMBL4572909

SCHEMBL4572909

CCS(=O)(=O)OCCS(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
USP2 O75604 2/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MMP9 P14780 1/20 0.36
ALOX15 P16050 1/20 0.36
NLRP3 Q96P20 1/20 0.33
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25630346 0.82 CA1 (0.40) CA1CA2
SCHEMBL9543126 0.80 CA1 (0.41) CA1CA2USP2TSHRKDM4E
SCHEMBL2329581 0.79 LMNA (0.38) CA1CA2USP2TSHRKDM4E
SCHEMBL164302 0.78 USP2 (0.60) CA1CA2USP2TSHRKDM4E
SCHEMBL17491112 0.78 USP2 (0.39) CA1CA2USP2TSHRKDM4E
SCHEMBL30164353 0.77 CA1 (0.39) CA1CA2USP2TSHRKDM4E
SCHEMBL13481842 0.76 TSHR (0.38) CA1CA2USP2TSHRKDM4E
SCHEMBL14444719 0.76 USP2 (0.57) CA1CA2USP2TSHRKDM4E
SCHEMBL575603 0.75 TSHR (0.55) CA1CA2USP2TSHRKDM4E
SCHEMBL776569 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250337021-A1 ELECTRODE FOR LITHIUM ION BATTERIES, AND LITHIUM ION BATTERY SUMITOMO SEIKA CHEMICALS (JP) 2025-10-30 US disclosed
US-20250323274-A1 LITHIUM-ION BATTERY ELECTRODE AND LITHIUM-ION BATTERY SUMITOMO SEIKA CHEMICALS (JP) 2025-10-16 US disclosed
EP-4510241-A1 LITHIUM-ION BATTERY ELECTRODE AND LITHIUM-ION BATTERY Sumitomo Seika Chemicals Co., Ltd. (JP) 2025-02-19 EP disclosed
EP-4507038-A1 ELECTRODE FOR LITHIUM ION BATTERIES, AND LITHIUM ION BATTERY Sumitomo Seika Chemicals Co., Ltd. (JP) 2025-02-12 EP disclosed
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-15 US disclosed
WO-2008055013-A2 5-OXO-5,8 - DIHYDRO - PYRIDO - PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE FLT3, FES, ALK CA1 3911/4885CA2 1974/4885USP2 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.